Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

Subjects:

NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

Subjects:

Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

Subjects:

Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

Subjects:

ZLN005 increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

Subjects:

Comparisons of mean values of lipid profiles of <i>H</i>. <i>pylori</i>-infected and non-infected study participants at Jimma Medical Hospital, 2023. by Negussie Sarbecha (20108068)

Subjects:

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adju... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the simple steatosis (SS) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and... by Laia Bertran (3685147)

Pathways analysis of ERCC1 based on CWP metabolome and proteome. by Hao Deng (409186)

Subjects:

Mean uncertainty of <i>boro</i> rice yields estimated by random forest model from 2002–2021. by Varun Tiwari (9258130)

Subjects:

S1 Data - by Hao Deng (409186)

Subjects:

Mean concentrations of sum sesquiterpenes and single sesquiterpenes: β-caryophyllene, α-humulene, δ-selinene, γ-cadinene, δ-cadinene, nerolidol, maaliol, germacrene D-4-ol, spathul... by Valtcho D. Zheljazkov (627617)

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Image 2_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg by Joseph W. P. Nakoa (21796214)

Image 3_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg by Joseph W. P. Nakoa (21796214)

Image 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg by Joseph W. P. Nakoa (21796214)

Table 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.xlsx by Joseph W. P. Nakoa (21796214)

Supplementary Material for: Decreased Lactococcus lactis and propionic acid in feces of patients with Moyamoya disease: Possible implications of immune dysregulation by figshare admin karger (2628495)

“…Results: There were no significant differences in α- and b-diversities among feces from the MMD patients and controls. …”